Identification of receptor ligands with phage display peptide libraries

Journal of Nuclear Medicine

Volumn 40, Issue 5, 1999, Pages 883-888

  Koivunen, Erkki ^b   Arap, Wadih ^b   Rajotte, Daniel ^b   Lahdenranta, Johanna ^b   Pasqualini, Renata ^a  

^a BURNHAM INSTITUTE   (United States)

^b NONE

Author keywords

Biopanning; Integrins; Ligands; Peptide libraries; Phage display; Receptors; Targeting

Indexed keywords

CARBOHYDRATE ANTIBODY; CONCANAVALIN A; ERYTHROPOIETIN RECEPTOR; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; LIGAND; PEPTIDE LIBRARY; PROTEIN ANTIBODY; THROMBOPOIETIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING KINETICS; BIOPANNING; CANCER RADIOTHERAPY; HUMAN; HUMAN CELL; ISOLATION PROCEDURE; LIGAND BINDING; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; TECHNOLOGY;

ANIMALS; BACTERIOPHAGES; HUMANS; INTEGRINS; LIGANDS; MICE; PEPTIDE LIBRARY; RECEPTORS, CELL SURFACE;

EID: 0032934258     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Smith G. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 1985;228:1315-1317.
2. Smith GP, Scott JK. Libraries of peptide and proteins displayed on filamentous phage. Methods Enzymol. 1993;217:228-257.
3. Cortese R, Monaci P, Luzzago A. et al. Selection of biologically active peptides by phage display of random peptide libraries. Curr Opin Biotechnol. 1996;7:616-621.
4. Burrit JB, Bond CW, Doss KW, Jesaitis AJ. Filamentous phage display of oligopeptide libraries. Anal Biochem. 1996;238:1-13.
5. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996;12:697-715.
6. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature. 1990;348:552-554.
7. Griffits AD, Duncan AR. Strategies for selection of antibodies by phage display. Curr Opin Biotechnol. 1998; 9:102-108.
8. Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science. 1990;249:386-390.
9. Wrighton NC, Farrell FX, Chang R, et al. Small peptides as potent mimetics of the protein hormone erythropoietin. Science. 1996;273:458-464.
10. 1 integrin from phage display library. J Biol Chem. 1993;268:20205-20210.
11. Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature. 1996;380:364-366.
12. Cwirla SE, Peters EA, Barrett RW, Dower WJ. Peptides on phage: a vast library of peptides for identifying ligands. Proc Natl Acad Sci USA 1990;87:6378-6382.
13. Folgori A, Tafi R, Meola A, et al. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J. 1994;13:2236-2243.
14. Cortese I, Tafi R, Grimaldi LME, Martino G, Nicosia A, Cortese R: Identification of peptides specific for CSF antibodies in multiple sclerosis using phage antibodies. Proc Natl Acad Sci USA. 1996;11063-11067.
15. Popkov M, Lussier I, Medvedkine V, Esleve P-O, Alakhov V, Mandeville R. Multidrug-resistance drug-binding peptides generated by using a phage display library. Eur J Biochem. 1998;251:155-163.
16. Magliani W, Polonelli L, Conti S, et al. Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes. Nature Med. 1988;4:705-709.
17. Hammer J, Takacs B, Sinigaglia F. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med. 1992;176:1007-1013.
18. Davenport MP, Quinn CL, Valsasnini P, Sinigaglia F, Hill AV, Bell JI. Analysis of peptide-binding motifs for two disease associated HLA-DR13 alleles using an M13 phage display library. Immunology. 1996;88:482-486.
19. Ruoslahti E, Pierschbacher M. New perpectives in cell adhesion: RGD and integrins. Science. 1987; 238:491-497.
20. Ruoslahti E. Integrins. J Clin Invest. 1991;87:1-5.
21. O'Neil KT, Hoess RH, Jackson SA, Swamy RN, Mousa SA, DeGrado WF. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library. Proteins: Struct Fund Genet. 1992;14:509-515.
22. Koivunen E, Wang B, Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Bio/ Technology. 1995;13:265-270.
23. 1 integrin from a phage display library. J Cell Biol. 1994;124:373-380.
24. 3 selected from random phage display libraries. Biochemistry. 1995;34:3948-3955.
25. Murayama O, Nishida H, Sekiguchi K. Novel peptide ligands for integrin alpha 6 beta 1 selected from a phage display library. J Biochem. 1996, 120:445-451.
26. Feng Y, Chung D, Garrard L, et al. Peptides derived from the complementarity-determining regions of anti-Mac-1 antibodies block intercellular adhesion molecule-1 interaction with Mac-1. J Biol Chem. 1998;273:5625-5630.
27. Ricklies RJ, Botfield MC, Zhou X-M, Henry PA, Brugge JS,Zoller MJ. Phage display selection of ligand residues important for Src homology 3 domain binding specificity. Proc Natl Acad Sci USA. 1995;92:10909-10913.
28. Sparks AB, Quilliam LA, Thorn JM, Der CJ, Kay BK. Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries. J Biol Chem. 1994;269:23853-23856.
29. Cheadle C, Ivashchenko Y, South V, et al. Identification of a Src SH3 domain binding motif by screening a random phage display library. J Biol Chem. 1994;269:24034-24039.
30. Dente L, Vetriani C, Zucconi A, et al. Modified phage peptide libraries as a tool to study specificity of phosphorylation and recognition of tyrosine containing peptides. J Mol Biol. 1997;694-703.
31. Gram H, Schmitz R, Zuber JF, Baumann G. Identification of phosphopeptide ligands for the Src-homology 2 (SH2) domain of Grb2 by phage display. Eur J Biochem. 1997;246:633-637.
32. Oligino L, Lung FD, Sastry L, et al. Nonphosphorylated peptide ligands for the Grb2 Src homology 2 domain. J Biol Chem. 1997;272:29046-29052.
33. Oldenburg KR, Loganathan D, Goldstein IJ, Schultz PG, Gallop MA. Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc Natl Acad Sci USA. 1992;89:5393-5397.
34. Scott JK, Loganathan D, Easley RB, Gong X, Goldstein IJ. A family of concanavalin A-binding peptides from a hexapeptide epitope library. Proc Natl Acad Sci USA. 1992;89:5398-5402.
35. Young AC, Valadon P, Casadevall A, Scharff MD, Sacchettini JC. The three-dimensional structures of a polysaccharide binding antibody to Cryptococcus neoformans and its complex with a peptide from a phage display library: implications for the identification of peptide mimotopes. J Mol Biol. 1997;274:622-643.
36. Phalipon A, Folgori A, Arondel J, et al. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Eur J Immunol. 1997;2620-2625.
37. Martens CL, Cwirla SE, Lee RY-W, et al. Peptides which bind to E-selectin and block neutrophil adhesion. J Biol Chem. 1995;270:21129-21136.
38. Pasqualini R, Koivunen E, Ruoslahti E. A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins. J Cell Biol. 1995;130:1189-1196.
39. Hong SS, Boulanger P. Protein ligands of the human adenovirus type 2 outer capsid identified by biopanning of a phage-displayed peptide library on separate domains of wild-type and mutant penton capsomers. EMBO J. 1995;14:4714-4727.
40. Lauvrak V, Brekke OH, Ihle O, Lindqvist BH. Identification and characterization of Clq-binding phage displayed peptides. Biol Chem. 1997;378:1509-1519.
41. Welply JK, Steininger CN, Caparon M, et al. A peptide isolated by phage display binds to ICAM-1 and inhibits binding to LFA-1. Proteins. 1996;26:262-270.
42. Wrighton NC, Farrell FX, Chang R, et al. Small peptides as potent mimetics of the protein hormone erythropoietin. Science. 1996;273:458-463.
43. Cwirla SE, Balasubramanian F, Duffin DJ, et al. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science. 1997;1696-1699.
44. Johnson DL, Farrell FX, Barbone FP, et al. Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. Biochemistry. 1998; 37:3699-3710.
45. Goodson RJ, Doyle MV, Kaufman SE, Rosenberg S. High-affinity urokinase receptor antagonists identified with bacteriophage peptide display. Proc Natl Acad Sci USA. 1994;91:7129-7133.
46. Szardenings M, Tornroth S, Mutulis F, et al. Phage display selection on whole cells yields a peptide specific for melanocortin receptor 1. J Biol Chem. 1997;31:27943-27948.
47. Doorbar J, Winter G. Isolation of a peptide antagonist to the thrombin receptor using phage display. J Mol Biol. 1994;244:361-369.
48. Hong SS, Karayan L, Tournier J, Curiel DT, Boulanger PA. Adenovirus type 5 fiber knob binds to MHC class I a2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 1997;16:2294-2306.
49. Pulli T, Koivunen E, Hyypia T. Cell-surface interactions of echovirus 22. J Biol Chem. 1997;272:21176-21180.
50. Heiskanen T, Lundkvist A, Vaheri A, Lankinen H. Phage-displayed peptide targeting on the Puumala Hantavirus neutralization site. J Virol. 1997;71:3879-3885.
51. BouHamdan M, Xue YN, Baudat Y, et al. Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins. J Biol Chem. 1998;273:8009-8016.
52. Barry MA, Dower WJ, Johnston SA. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nature Med. 1996;2:299-305.
53. Watters JM, Telleman P, Junghans RP. An optimized method for cell-based phage display panning. Immunotechnology. 1997;3:21-29.
54. Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest. 1998;102:430-437.
55. Pasqualini R, Koivunen E, Ruoslahti E: Alpha v integrins as receptors for tumor targeting by circulating ligands. Nature Biotechnol. 1997;15:542-546.
56. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 1998;279:377-380.
57. Brooks PC, Clark RAF, Cheresh DA. Requirement of vascular integrin for angiogenesis. Science. 1994;264:569-571.
58. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA. Antitntegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest. 1995;96:1815-1822.
59. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1995;1:27-31.
60. Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994;79:1157-1164.
61. Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nature Med. 1996;2:529-533.
62. Arap W, Pasqualini R, Ruoslahti E. Chemotherapy targeted to tumor vasculature. Curr Opinion Oncol. 1998;10:560-565.
63. 3-targeted magnetic resonance imaging. Nature Med. 1998;4:623-626.
64. Jain RK. The next frontier of molecular medicine: delivery of therapeutics. Nature Med. 1988;6:655-657.
65. 212Bi-anli-Tac. Cancer Res. 1994;54:4362-1370.
66. 213Bi: an alpha particle emitter. Nucl Med Biol. 1998;24:241-256.